Inventor · disambiguated record
Fabrizio Gasparini
Also filed as: GASPARINI FABRIZIO
8 granted patents·15 pending applications·95 citations·filing 2000–2025
85Inventor score
Top patents by PatentIndex Score
23 records- 0191US6656957B1Pyridine derivativesNOVARTIS AG·Filed 2000·Granted Dec 2, 2003·55 cites·8 claims
- 0289US11492402B2TREM2 stabilizing antibodiesNOVARTIS AG·Filed 2019·Granted Nov 8, 2022·11 cites·28 claims
- 0385US8703809B2Combination productsGOMEZ-MANCILLA BALTAZAR·Filed 2009·Granted Apr 22, 2014·15 cites·2 claims
- 0480US7348353B2Acetylene derivatives having mGluR 5 antagonistic activityNOVARTIS AG·Filed 2002·Granted Mar 25, 2008·11 cites·6 claims
- 0569US12201612B2Use of mavoglurant in the reduction of alcohol use or in preventing relapse into alcohol useNOVARTIS AG·Filed 2018·Granted Jan 21, 2025·1 cites·13 claims
- 0669US11878001B2Use of mavoglurant in the reduction of cocaine use or in preventing relapse into cocaine useNOVARTIS AG·Filed 2018·Granted Jan 23, 2024·1 cites·13 claims
- 0769US2025215080A1Trem2 stabilizing antibodiesNOVARTIS AG·Filed 2025·Application pending·0 cites
- 0864US8536229B2Acetylene derivatives having MGluR 5 antagonistic activityGASPARINI FABRIZIO·Filed 2011·Granted Sep 17, 2013·1 cites·1 claims
- 0958US2008146647A1Acetylene derivatives having mglur 5 antagonistic activityGASPARINI FABRIZIO·Filed 2008·Application pending·0 cites
- 1056US2024082215A1Use of mglur5 antagonists for treating gambling disorderNOVARTIS AG·Filed 2021·Application pending·0 cites
- 1156US2024050408A1Use of mglur5 antagonists for treating amphetamine addictionNOVARTIS AG·Filed 2021·Application pending·0 cites
- 1255US2023270720A1Mavoglurant, a mglur5 antagonist, for use in the treatment in the reduction of opioid useNOVARTIS AG·Filed 2021·Application pending·0 cites
- 1354US2013331568A1Acetylene derivatives having mglur 5 antagonistic activityGASPARINI FABRIZIO·Filed 2013·Application pending·0 cites
- 1451US2010249136A1Organic compoundsUMBRICHT DANIEL·Filed 2008·Application pending·0 cites
- 1549US2007265279A1Use of mGluR5 antagonists for the treatment of pruritic conditionsGASPARINI FABRIZIO·Filed 2007·Application pending·0 cites
- 1649US2022175793A1The use of an mglur5 antagonist for treating opioid analgesic toleranceNOVARTIS AG·Filed 2020·Application pending·0 cites
- 1746US2014194423A1Combination productsGOMEZ-MANCILLA BALTAZAR·Filed 2014·Application pending·0 cites
- 1844US8674110B2Pyridylacetylenes for use as radiotracers and imaging agentsGASPARINI FABRIZIO·Filed 2004·Granted Mar 18, 2014·0 cites·2 claims
- 1944US2004106582A1Use of mglur5 antagonists for the treatment of pruritic conditionsFiled 2002·Application pending·0 cites
- 2042US2001056084A1MGluR5 antagonists for the treatment of pain and anxietyFiled 2001·Application pending·0 cites
- 2142US2008207749A1Use of Mglur5 (Esp. Afq056) in Gi (Esp.Gerd)NOVARTIS AG·Filed 2006·Application pending·0 cites
- 2242US2014142318A1Pyridylacetylenes for use as radiotracers and imaging agentsGASPARINI FABRIZIO·Filed 2014·Application pending·0 cites
- 2335US2015272929A1Organic compoundsUMBRICHT DANIEL·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Fabrizio Gasparini files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →